Association of Smoking Status with Efficacy of First-line Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancers: A Systematic Review and Meta-analysis

Background: Although smoking status has potential as a biomarker for immune checkpoint blockade in advanced non-small cell lung cancer (NSCLC), its clinical significance remains obscure. This meta-analysis aims to assess the impact of the smoking status on the efficacy of first-line immunotherapy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jinchul, Ha, Hyerim, Park, Jisun, Cho, Jinhyun, Lim, Joo Han, Lee, Moon Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771515/
https://www.ncbi.nlm.nih.gov/pubmed/35069886
http://dx.doi.org/10.7150/jca.65374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771515/
https://www.ncbi.nlm.nih.gov/pubmed/35069886
http://dx.doi.org/10.7150/jca.65374

Ejemplares similares